Markets:

Overview

News

Currencies

International

Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

24.79 -0.47 (-1.86%)

Streaming Delayed Price Updated: 3:00 PM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >

Expert Ratings for PROCEPT BioRobotics ↗

November 04, 2022

Within the last quarter, PROCEPT BioRobotics (NASDAQ:PRCT) has observed the following analyst ratings:

Via Benzinga

What 4 Analyst Ratings Have To Say About PROCEPT BioRobotics ↗

November 04, 2022

Over the past 3 months, 4 analysts have published their opinion on PROCEPT BioRobotics (NASDAQ:PRCT) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

November 03, 2022

From PROCEPT BioRobotics

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022 ↗

October 25, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 ↗

October 31, 2022

Upgrades

Via Benzinga

PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022

October 12, 2022

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics Announces $52 Million Debt Refinancing

October 10, 2022

From PROCEPT BioRobotics

Via GlobeNewswire

Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year ↗

October 05, 2022

Biotech isn't the only place to make money in health care this year.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022 ↗

September 02, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022 ↗

July 15, 2022

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More ↗

June 22, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy.

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

Procept BioRobotics' Aquablation Therapy Shows Encouraging Five-Year Data In Prostate Gland Enlargement ↗

February 15, 2022

Procept BioRobotics Corp (NASDAQ: PRCT) announced five-year results from the WATER study comparing Aquablation therapy to TURP, the historical standard of care for...

Via Benzinga

Earnings Scheduled For March 8, 2022 ↗

March 08, 2022

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...

Via Benzinga

6 Underperforming IPO Stocks To Buy On The Dip ↗

February 04, 2022

Here are six 2021 IPO stocks to buy on the dip, according to Bank of America.

Via Talk Markets

6 Underperforming IPO Stocks To Buy On The Dip ↗

February 04, 2022

The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels last...

Via Benzinga

Where PROCEPT BioRobotics Stands With Analysts ↗

November 05, 2021

Over the past 3 months, 6 analysts have published their opinion on PROCEPT BioRobotics (NASDAQ:

Via Benzinga

PROCEPT BioRobotics Corporation (PRCT) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

PRCT earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021 ↗

October 11, 2021

Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ:

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 19, 2022

During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by...

Via Benzinga

56 Biggest Movers From Yesterday ↗

September 17, 2021

Check out these big penny stock gainers and losers Losers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48. MacroGenics, Inc. (NASDAQ...

Via Benzinga

53 Biggest Movers From Yesterday ↗

September 16, 2021

Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...

Via Benzinga

Topics Initial Public Offering

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

IPO Previews For The Week ↗

September 12, 2021

With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these...

Via Benzinga

Topics Initial Public Offering

The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs ↗

September 12, 2021

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week. Humanigen, Inc. (NASDAQ: HGEN) was among the biggest...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.